U.S. Metals and Mining Stock News

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

The Badger Meter, Inc. ( NYSE:BMI ) share price has fared very poorly over the last month, falling by a substantial...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Four Seasons Education (Cayman) Inc. ( NYSE:FEDU ) shares have continued their recent momentum with a 28% gain in the...

Let's talk about the popular Ferguson Enterprises Inc. ( NYSE:FERG ). The company's shares received a lot of attention...

Omega Flex ( NASDAQ:OFLX ) Second Quarter 2025 Results Key Financial Results Revenue: US$25.5m (up 3.7% from 2Q 2024...

X Financial ( NYSE:XYF ) shares have retraced a considerable 25% in the last month, reversing a fair amount of their...

Despite an already strong run, BT Brands, Inc. ( NASDAQ:BTBD ) shares have been powering on, with a gain of 26% in the...

On July 21, 2025, LTC Properties entered into a new unsecured credit agreement replacing its prior facility, featuring an initial revolving commitment of US$600 million and potential total maximum commitments of up to US$1.2 billion, with maturity extended to 2029 and a one-year extension option. This refinancing enhances LTC’s financial flexibility and liquidity, allowing the company to respond more readily to market opportunities and potential capital needs. We’ll now explore how LTC’s...

Organon is set to report quarterly earnings with analysts expecting earnings per share of US$0.94 and revenues of US$1.55 billion, both reflecting year-over-year declines, according to projections released ahead of the August 5 announcement. While the forecasts indicate pressure on top-line growth and profitability, Organon's favorable analyst rating reflects confidence in its potential to withstand near-term earnings softness. We will explore how these anticipated earnings declines factor...

International Seaways is expected to report a year-over-year decline in earnings and revenue for the June 2025 quarter, with earnings results released after August 6, 2025, following a period of increased bearishness from analysts and downward earnings revisions. Options market activity around International Seaways has shown very high implied volatility, reflecting heightened investor uncertainty and the potential for significant stock movement in anticipation of the company’s upcoming...

Star Bulk Carriers Corp., a Greece-based dry bulk shipping company, announced a US$0.05 per share dividend, the 17th consecutive quarter of capital returns, while recently reporting revenue and EPS figures that topped consensus estimates. While the company has outperformed on recent earnings, investor caution has persisted, with skepticism about Star Bulk's ability to deliver on future growth forecasts despite positive analyst revisions. We will review how Star Bulk’s stronger-than-expected...

Solaris Energy Infrastructure, Inc. recently reported strong second quarter 2025 results, with revenue reaching US$149.33 million and net income rising to US$11.96 million, and approved its 28th consecutive quarterly dividend of US$0.12 per share for payment in September 2025. Alongside record financial performance, Solaris announced a dual listing on NYSE Texas to strengthen its presence in the region and support further business growth. With Solaris raising future profit guidance on the...

Recently, analysis highlighted that Ligand Pharmaceuticals' price-to-sales ratio remains well above the industry average as revenue growth continued to lag expectations over the last three years. This elevated valuation signals ongoing investor optimism, even as analysts forecast the company's future growth to fall short of industry peers. We'll examine how heightened investor caution about Ligand's revenue prospects could impact the company's existing investment case going forward. The end...

Blackstone Mortgage Trust recently reported its second-quarter 2025 results, with revenue of US$38.81 million and net income of US$6.97 million, marking a turnaround from a net loss in the prior year; the company also announced a joint venture to acquire a portfolio of performing commercial mortgage loans and filed new shelf registrations for securities offerings. This quarter's earnings results were accompanied by the cancellation of the scheduled conference call due to a tragedy at the...

In recent weeks, LGI Homes launched several new communities across North Carolina and Colorado, most notably the grand opening of Rhyne Court in Gastonia, which introduces 130 townhomes starting at US$249,900 with buyer incentives and event-exclusive discounts. This wave of launches highlights LGI Homes’ ongoing focus on expanding its footprint in high-demand, growth-oriented markets with innovative and affordable product options. We’ll examine how the expansion into new markets with broad...

Innoviva, Inc. recently reported managing its net debt conservatively at US$69.8 million as of March 2025, backed by strong cash reserves and interest coverage of 106 times EBIT. An interesting insight is the company's EBIT grew by 32% over the past year, strengthening its ability to manage debt efficiently. We’ll explore how Innoviva’s strong earnings expansion and firm balance sheet shape the company’s investment narrative moving forward. The latest GPUs need a type of rare earth metal...

Celcuity recently announced highly positive topline results from its Phase 3 VIKTORIA-1 trial, in which gedatolisib, combined with other therapies, significantly reduced the risk of disease progression or death for patients with HR+/HER2- advanced breast cancer and showed an improved safety profile, with plans to submit a New Drug Application to the FDA by year-end. This outcome marks a potential advance in targeted cancer therapy, as both triplet and doublet combinations outperformed prior...

PotlatchDeltic Corporation reported its second quarter 2025 earnings, revealing net income of US$7.35 million and significant share repurchases totaling US$55.9 million during the quarter. Despite a year-over-year dip in quarterly net income, the company's strong Timberlands and Real Estate results, plus a major buyback, underline management's confidence looking ahead. We’ll explore how the latest earnings, combined with the robust buyback activity, may shape PotlatchDeltic’s forward...

Haemonetics is set to report quarterly results for the period ended June 2025, with analysts expecting year-over-year declines in both earnings and revenue. Despite these expectations, a recent uptick in analyst sentiment and a positive Earnings ESP highlight renewed optimism regarding the company’s upcoming earnings performance. With sentiment shifting ahead of the earnings release, we'll look at how these heightened expectations may influence Haemonetics' investment narrative. Uncover the...

Inspire Medical Systems recently experienced a slowdown in procedure volumes as patients delayed surgeries, awaiting the launch of the new Inspire 5 device, while the company also faced investor concerns about rising competition and the impact of GLP-1 weight loss drugs on sleep apnea treatments. This combination of postponed procedures and evolving market dynamics underscores how the timing of innovations and external healthcare trends can significantly affect operational performance and...

AGNC Investment Corp. recently announced its second-quarter 2025 results, reporting a net loss of US$140 million, a sharp increase from a net loss of US$48 million in the same period last year, with basic and diluted loss per share from continuing operations at US$0.17 compared to US$0.11 previously. This widening loss marks a shift that could influence how investors assess AGNC's current financial resilience and outlook for recovery. With the company reporting a significantly larger net...

In July 2025, Elanco Animal Health received European Commission approval for Zenrelia™ (ilunocitinib), a once-daily oral JAK inhibitor for dogs with allergic and atopic dermatitis, marking a new entry in the EU canine dermatology market. This regulatory milestone follows successful clinical trials against the market incumbent and expands Zenrelia's footprint, reinforcing Elanco’s global innovation and geographic growth strategy. We'll explore how EU approval for Zenrelia could shape Elanco's...

In recent days, First American Financial Corporation reported strong second quarter results, completed a share buyback program, announced a new US$300 million repurchase authorization, and filed a US$113.80 million common stock shelf registration tied to an ESOP-related offering. These moves highlight both management’s ongoing capital return efforts and the company’s improved operating performance, as evidenced by higher revenues and net income versus the prior year. We'll explore how the...